🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

CDC confirms human case of bird flu in Missouri

Published 09/06/2024, 06:07 PM
Updated 09/06/2024, 06:40 PM

(Reuters) - The U.S. Centers for Disease Control and Prevention on Friday confirmed a human case of avian influenza A reported by the state of Missouri.

The case was identified through that state's seasonal flu surveillance system, the agency said.

The case was confirmed on Thursday, the CDC said, adding that an investigation into the potential exposure is ongoing by the Missouri Department of Health and Senior Services.

The patient, who was hospitalized, had underlying medical conditions and was treated with influenza antiviral medications. The patient was subsequently discharged and has recovered.

There is no immediate known animal exposure and no ongoing transmission among close contacts or otherwise has been identified.

This is the 14th human case of H5 reported in the United States during 2024 and the first case of H5 without a known occupational exposure to sick or infected animals.

While other novel flu cases have been detected through the country's national flu surveillance system, this is the first time that system has detected a case of H5, the CDC said.

H5 bird flu is widespread in wild birds worldwide and is causing outbreaks in poultry and U.S. dairy cows, with several recent human cases in U.S. dairy and poultry workers.

While, outbreaks of H5 have been reported in commercial and backyard poultry flocks in 2024, outbreaks in cattle have not been reported in Missouri.

Missouri's last reported case of bird flu in a commercial poultry flock was in February, according to USDA.

H5N1 bird flu has been detected in wild birds in the state in the past.

Fourteen U.S. states have reported an outbreak of the H5N1 virus in dairy cattle.

© Reuters. Test tubes is seen labelled

The virus's jump to cows from birds has heightened concerns it could adapt to spread among humans.

The CDC said the risk to the general public from H5N1 remains low, based on available data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.